These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5383669)

  • 1. [Radiotherapy and immune reactions of spleen cells in experimental tumors].
    Juliani G; Cirillo R; Ballaira L; Fava C
    Minerva Radiol; 1969 Nov; 14(11):494-8. PubMed ID: 5383669
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune reactions in Ehrlich ascites tumour-bearing mice.
    Olinescu A; Babeş S; Piţur I
    Arch Roum Pathol Exp Microbiol; 1980; 39(3):249-57. PubMed ID: 7018456
    [No Abstract]   [Full Text] [Related]  

  • 4. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
    Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
    Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
    [No Abstract]   [Full Text] [Related]  

  • 5. [The immunologic reactivity of mice with the ascitic form of Ehrlich carcinoma].
    Botev B; Markholev L
    Biull Eksp Biol Med; 1969 Dec; 68(12):70-1. PubMed ID: 5382331
    [No Abstract]   [Full Text] [Related]  

  • 6. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R; Chattopadhyay U
    Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
    Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
    [No Abstract]   [Full Text] [Related]  

  • 8. [Phytohaemagglutinin (PHA) induced cytotoxicity II: The effect of PHA stimulated spleen cells to Erlich tumor cells in vivo (author's transl)].
    Aoki S
    Nihon Hinyokika Gakkai Zasshi; 1978 Nov; 69(11):1404-11. PubMed ID: 739705
    [No Abstract]   [Full Text] [Related]  

  • 9. Study on the immunological reactivity of mice with solid Ehrlich adenocarcinoma.
    Botev B; Marholev L
    C R Acad Bulg Sci; 1970; 23(4):451-3. PubMed ID: 4919477
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of splenectomy on the regression of transplantable tumors.
    Ferrer JF; Mihich E
    Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
    [No Abstract]   [Full Text] [Related]  

  • 11. [The relative biologic effectiveness of fast electrons generated by the linear accelerator LUE-25].
    Kozlov AP; Akimov AA; Skachkov AP
    Med Radiol (Mosk); 1971 Mar; 16(3):69-71. PubMed ID: 4997701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radiotherapy and immunological phenomena in the evolution of Ehrlich's tumor].
    Juliani G; Piccotti F; Cirillo R
    Radiol Med; 1968 Jun; 54(6):556-73. PubMed ID: 5201412
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on immune response of experimental tumors--observations on the immune response of lymph nodes of mice bearing implanted Ehrlich ascitic tumor or sarcoma 180 (author's transl)].
    Chen QF; Zhou SL; Liu QR
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):193-6. PubMed ID: 7227183
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypoxic proton radiotherapy of solid Ehrlich tumors with different dose magnitudes].
    Kozin SV; Zolotov VA; Ponomareva NA
    Med Radiol (Mosk); 1984 Jul; 29(7):27-33. PubMed ID: 6087078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular antibody in mice bearing Ehrlich cancer. II. Properties of lymphoid cells from sensitized animal.
    Hara S
    Acta Med Okayama (1952); 1965 Apr; 19(2):99-106. PubMed ID: 4221944
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of exposure of different skin areas to low-power laser light].
    Glushkov OV; Novoselova EG; Cherenkov DA; Novoselova TV; Khrenov MO; Lunin SM; Chudnovskiĭ VM; Iusupov VI; Fesenko EE
    Biofizika; 2006; 51(1):123-35. PubMed ID: 16521562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Ehrlich ascites tumors growth in vivo by isologous liver and spleen RNA.
    Srebro Z; Kowalczyk K; Maroń K; Spisak-Plonka I; Weber M
    Folia Biol (Krakow); 1968; 16(2):207-10. PubMed ID: 5706511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.